MAC Clinical Research is currently conducting a trial to test a new oral medication for eczema. Eczema, or atopic dermatitis, is a chronic inflammatory skin disorder and is the most common form of the condition, affecting up to 20% of the general population.
An email has been sent to the employer to notify them of your new application.
The employer has up to 30 days (usually allot quicker!) to respond and either accept or decline your application. Once a response is received you will be emailed and you can view all responses via your members area.